About Us
Provectus Algae is an Australian biotech startup specialising in the optimisation of Algae to produce high-value compounds for use in a wide array of industries and applications.
The groundbreaking capabilities of the Provectus Algae team are enabled by a well-balanced fusion of its proprietary innovative technology and a thorough understanding of the unique biological traits of algae.
Follow us:
Executive Team
Nusqe Spanton
Founder & CEO
Algae and Aquaculture expert with 15 years experience in international aquaculture production, corporate management and marine biotechnology applications for public and private companies. Passionate and motivated leader with a proven track record in complex project delivery.
Board & Advisers
David Williams
Chairman, Board of Directors
Corporate, merger and acquisitions specialist and commercial lawyer for 35+ years
Tom Himstedt
Non-Executive Director
Tom is an operational executive with more than 20 years’ experience in vertically integrated food manufacturing, commercial product development and nutraceutical R&D.
Roslyn Hendriks
Adviser Biotechnology & Commercialisation
Raised $40M in high risk capital. Brought medical innovations to market. Former General Manager UniQuest commercialising research.
Garry Redlich
Adviser Biotechnology & Technical Scale-up
Successfully brought 2 drugs to advanced clinical development and 1 to global regulatory approval. Federal government level advisor.
Kevin Grant
Adviser Regulatory Requirements
35 years principal biochemist at Therapeutic Goods Administration (TGA)
Why Algae
High-value algae strains are heralded as the eco super-crop of the future but they have typically been difficult to grow in commercial quantities- until now.
We have the technology to capitalise on an existing market, mature it and be a driving force in the future of bioceuticals and aquaculture.